| scholarly article | Q13442814 |
| P50 | author | Antonella Liantonio | Q40102838 |
| Diana Conte Camerino | Q40102883 | ||
| Sabata Pierno | Q42518886 | ||
| Annamaria De Luca | Q42518905 | ||
| Jean-François Desaphy | Q51664518 | ||
| Bodvaël Fraysse | Q114515220 | ||
| Maria Paola Didonna | Q121362504 | ||
| P2093 | author name string | Roy G Smith | |
| Daniela Cocchi | |||
| Marcello Lograno | |||
| P2860 | cites work | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| A receptor in pituitary and hypothalamus that functions in growth hormone release | Q24308321 | ||
| A new generation of Ca2+ indicators with greatly improved fluorescence properties | Q27860793 | ||
| Primary structure and functional expression of a developmentally regulated skeletal muscle chloride channel | Q28571348 | ||
| Neuroendocrine control of growth hormone secretion | Q33604638 | ||
| Internal citrate ions reduce the membrane potential for contraction threshold in mammalian skeletal muscle fibers | Q34260195 | ||
| Peptidomimetic regulation of growth hormone secretion | Q34442387 | ||
| Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity | Q34635506 | ||
| Effects of chronic growth hormone treatment in aged rats on the biophysical and pharmacological properties of skeletal muscle chloride channels | Q35026185 | ||
| [125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis | Q35043705 | ||
| Characteristics of the chloride conductance in muscle fibers of the rat diaphragm | Q36407703 | ||
| Phosphorylation and IGF-1-mediated dephosphorylation pathways control the activity and the pharmacological properties of skeletal muscle chloride channels | Q42234720 | ||
| Protectant activity of hexarelin or growth hormone against postischemic ventricular dysfunction in hearts from aged rats. | Q47698286 | ||
| Partial recovery of skeletal muscle sodium channel properties in aged rats chronically treated with growth hormone or the GH-secretagogue hexarelin | Q47723400 | ||
| Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor | Q47862440 | ||
| GHRP-6 induces a biphasic calcium response in rat pituitary somatotrophs | Q48159850 | ||
| A New Orphan Receptor Involved in Pulsatile Growth Hormone Release | Q48213465 | ||
| Effect of long-term administration of Hexarelin on the somatotrophic axis in aged rats | Q48662201 | ||
| Bombesin receptors inhibit G protein-coupled inwardly rectifying K+ channels expressed in Xenopus oocytes through a protein kinase C-dependent pathway | Q48917120 | ||
| Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs | Q49084298 | ||
| The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans | Q50336243 | ||
| Modification by ageing of the tetrodotoxin-sensitive sodium channels in rat skeletal muscle fibres. | Q51502099 | ||
| Effects of aging on sarcoplasmic reticulum function and contraction duration in skeletal muscles of the rat. | Q51561179 | ||
| Changes of the biophysical properties of calcium-activated potassium channels of rat skeletal muscle fibres during aging. | Q53963663 | ||
| Growth hormone secretagogue binding sites in peripheral human tissues. | Q54414034 | ||
| Peptidomimetic Regulation of Growth Hormone Secretion | Q57319422 | ||
| Aging-associated down-regulation of ClC-1 expression in skeletal muscle: phenotypic-independent relation to the decrease of chloride conductance | Q59467401 | ||
| Aging and chloride channel regulation in rat fast-twitch muscle fibres | Q59467540 | ||
| Effects of aging on the mechanical threshold of rat skeletal muscle fibers | Q59467596 | ||
| Membrane ionic conductances in normal and denervated skeletal muscle of the rat during development | Q59467667 | ||
| Chloride channel regulation in the skeletal muscle of normal and myotonic goats | Q60612047 | ||
| Growth hormone (GH) and insulin-like growth factor I responses after treatments with an orally active GH secretagogue L-163,255 in swine | Q71733351 | ||
| The growth hormone secretagogue, L-692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors | Q72108163 | ||
| Growth hormone secretagogues: recent advances and applications | Q73102558 | ||
| Identification and characterization of a new growth hormone-releasing peptide receptor in the heart | Q73111084 | ||
| L-type Ca2+ channel-insulin-like growth factor-1 receptor signaling impairment in aging rat skeletal muscle | Q73475822 | ||
| Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin | Q73879575 | ||
| Altered turnover of calcium regulatory proteins of the sarcoplasmic reticulum in aged skeletal muscle | Q74263749 | ||
| Insulin-like growth factor-1 enhances rat skeletal muscle charge movement and L-type Ca2+ channel gene expression | Q74625227 | ||
| Chronic administration of taurine to aged rats improves the electrical and contractile properties of skeletal muscle fibers | Q77223682 | ||
| Overexpression of IGF-1 exclusively in skeletal muscle prevents age-related decline in the number of dihydropyridine receptors | Q77458446 | ||
| Growth Hormone Secretagogues: Physiological Role and Clinical Utility | Q77735557 | ||
| Growth hormone-independent cardioprotective effects of hexarelin in the rat | Q78180910 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 575-584 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Growth hormone secretagogues modulate the electrical and contractile properties of rat skeletal muscle through a ghrelin-specific receptor | |
| P478 | volume | 139 |
| Q41868299 | An olive oil-derived antioxidant mixture ameliorates the age-related decline of skeletal muscle function |
| Q34295366 | Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase |
| Q36993612 | Cardiac, skeletal, and smooth muscle regulation by ghrelin. |
| Q35541006 | ClC-1 chloride channels: state-of-the-art research and future challenges. |
| Q42518795 | Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance |
| Q41604256 | Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study |
| Q50201348 | Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia. |
| Q59467086 | Pharmacology of CLC Chloride Channels and Transporters |
| Q51747566 | Protein kinase C theta (PKCθ) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: a biophysical and gene expression study in mouse models lacking the PKCθ. |
| Q46314668 | Protein kinase C-dependent regulation of ClC-1 channels in active human muscle and its effect on fast and slow gating. |
| Q40495812 | Signal transduction mechanism of the seabream growth hormone secretagogue receptor |
| Q26744730 | Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery |
| Q34927551 | Therapeutic approaches to ion channel diseases |
Search more.